{"database": "lobbying", "table": "lobbying_activities", "rows": [[1660925, "85de51dc-7e5b-4132-bead-1496bfc15cb8", "Q1", "THE CORMAC GROUP, LLC", 66773, "HTG MOLECULAR DIAGNOSTICS, INC.", 2015, "first_quarter", "MED", "Medicare high end technology reimbursement issues", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2015-04-14T16:02:55.953000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1660925"], "units": {}, "query_ms": 0.596839003264904, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}